NAME |
POSITION TITLE |
|||
|
||||
EDUCATION/TRAINING |
||||
INSTITUTION AND LOCATION |
DEGREE |
YEAR(s) |
FIELD OF STUDY |
|
University of Chicago |
SB |
1969 |
Biochemistry (Honors) |
|
University of Chicago |
PhD |
1974 |
Biochemistry |
|
University of Chicago |
MD |
1975 |
Medicine (Honors) |
|
University of Chicago |
Post-Doc |
1975-76 |
Psychopharmacology Research |
|
1975-1976 Post-doctoral Fellow, Neuropsychopharmacology Research, Illinois State Psychiatric Institute
1976-1979 Psychiatry Resident, Department of Psychiatry, Michael Reese Hospital and Medical Center
1977-1979 Director, Lithium Transport Laboratory, Michael Reese Hospital and Medical Center
1983-1986 Associate Professor, Dept of Psychiatry, Community Health and Preventative Medicine, Northwestern University Medical School; Staff Psychiatrist, VA Lakeside Medical Center and Northwestern Memorial Hospital, Chicago, Illinois
1988-1992 Director, Midwest AIDS Biobehavioral Research Center (MABRC)
1986-1993 Associate Professor of Psychiatry, University of Michigan School of Medicine
Faculty A Associate, Institute for Social Research, Center for Political Studies
12/93 - 8/96 Associate Professor of Psychiatry and Behavioral Medicine, Med College Milwaukee, Milwaukee, WI
9/96 - 8/99 Professor of Epidemiology and Biostatistics, Univ. of Illinois at Chicago, School of Public Health
5/95-8/99 PI/Director, NIDA-funded AIM Project, Howard Brown Health Center, Chicago
8/1/99-8/2001 Chief, Addiction Medicine Program, Loyola University Medical Systems, Maywood, IL
8/1/99-8/2001 Professor of Psychiatry and Behavioral Neurosciences, Loyola Univ Medical School, Maywood, IL
10/99-9/02 Consultant Intervention Scientist, CDC-funded Multi-site Intervention Study of HIV+ IDUs, Einstein-NY Academy of Medicine-Montefiore Site, Brooklyn, NYC
7/01-11/01 Chief Psychiatrist, Angela Mental Health Center, Centralia, IL
2/02-5/02 Chief Psychiatrist, Community Counseling Center, Alton, IL
5/20/02-8/15/05 Psychiatrist and Addictionist, Horizons Behavioral Health, Centegra Health System, Crystal Lake, IL
1/2/04-9/30/04 Principal Investigator, SAMSHA funded “Hepatitis C Education and Training in Substance Abuse Treatment,” demonstration project
1999-present Chair, Behavioral Working Group of the Multicenter AIDS Cohort Study (MACS)
2005-present Co-Chair, Joint MACS-WIHS Behavioral Working Group
Honors
1969-1975 Medical Scientist Training Program Fellowship
1976 University of Chicago Medical Alumni Fellowship for Research
1977 Alpha Omega Alpha
1977-1979 Falk Fellowship, American Psychiatric Association
1979-1982 Career Development Award (Psychiatric Research Associate Level) VA Lakeside Medical Center
1980 Research Award, Illinois Psychiatric Society
1985 Research Achievement Award, Howard Brown Memorial Clinic, Chicago, Illinois
1989 Fellow, American Psychiatric Association
1995 Jane Adams/Howard Brown Award of National Lesbian/Gay Health Association
2001-2003 Selected as one of the Top Chicago Area Doctors, Castle & Connolly Publications
Ostrow DG, DiFranceisco W, Chmiel JS, Wagstaff D, Wesch J. A case-control study of HIV-1 seroconversion and
risk-related behaviors in the Chicago MACS/CCS cohort, 1984-1992. American J of Epidemiology, 142:875-883,
1995.
DiFranceisco W, Ostrow DG, Chmiel JS. Sexual adventurism, high-risk behavior, and human immunodeficiency
virus-1 seroconversion among the Chicago MACS-CCS cohort, 1984-1992: A Case-control study. Sexually
Transmitted Diseases, 23 (6): 453-460, 1996.
Ostrow DG. Disease, disease course and psychiatric manifestations of HIV. In O’Connor MF, Yalom, ID (Eds.):
Treating the Psychological Consequences of HIV. Jossey-Bass, San Francisco, pp. 33-72, 1997.
Ostrow DG. Psychiatric considerations in human immunodeficiency virus disease. In DeVita VT, et al. (Eds.):
AIDS Etiology, Diagnosis, Treatment and Prevention, Fourth Edition. Lippincott-Raven, Philadelphia, pp.
541-550, 1997.
Ostrow DG. NIH consensus panel recommends policy changes to implement AIDS prevention strategies, but
does anyone want to listen? ATN Newsletter, 4(5), pp 1-2, 1997.
Ostrow DG and McKirnan DJ. Prevention of substance-related high-risk sexual behavior among gay men: Critical
review of the literature and proposed harm reduction approach. Journal Gay & Lesbian Medical Association 1 1997:97-110.
Kalichman SC, Ostrow DG. and Ramachandran, B. Protease Inhibitors and the New AIDS Combination Therapies:
Implications for Psychological Services. Professional Psychology: Research and Practice. 4:349-356, 1999.
Ostrow DG, Kalichman, SC (Eds.): Psychosocial and Public Health Impacts of New HIV Therapies. Plenum Press,
New York, 1999.
Ostrow DG, DiFranceisco W, Wagstaff D. The Coping and Change Sexual Behavior and Behavior Change
Questionnaire. In Davis, CM, et al. (Eds): Handbook of Sexuality-Related Measures. Sage, Thousand Oaks, pp.
547-553, 1998.
Ostrow DG, McKirnan DJ, Vanable PA, Hope BA. The Impact of New Combination HIV Therapies on Knowledge,
Attitudes, and Behaviors among Chicago Gay Men. Proc. 12th World AIDS Conf. Abstract, July 1998.
Ostrow DG, Vanable PA, McKirnan DJ, Brown L. Hepatitis and HIV risk among DU-MSM: Demonstration of
Hart’s Law of Inverse Care Access and application to HIV. Proc. 12th World AIDS Conf. Late Breaker Abstract, July 1998.
Vanable PA, McKirnan DJ, Ostrow DG, Hope BA. Proc. HIV Sexual Risk Among Subgroups of Drug and Alcohol-
Involved Men Who Have Sex with Men. 12th World AIDS Conf. Abstract , 1998.
Ostrow DG. Practical Prevention Issues. In Ostrow & Kalichman, (Eds.) Psychosocial & Public Health Impacts of
New HIV Therapies. Kluwer Academic- Plenum Press, NY, 1999, pp.151-170.
Ostrow DG. The role of drugs in the sexual lives of MSM: Continuing barriers to researching this question. AIDS &
Behavior, 4, 205-219, 2000.
DeMarco FJ, Ostrow DG, and DiFranceisco W. General and AIDS-specific stress, coping, and psychological distress
in the biracial Coping and Change Study cohort of gay men. AIDS and Behavior, 3, 177-186, 1999.
Ostrow DG, Vanable PA, McKirnan DJ, Brown L. Hepatitis and HIV risk among Drug Using-Men who have Sex
with Men: Demonstration of Hart’s Law of Inverse Care Access and application to HIV Prevention. Journal of the Gay & Lesbian Medical Association, 3, 127-136, 1999.
DiFranceisco W, Ostrow DG, Adib DS, and Chmiel J. Predictors of long-term maintenance of safer sex and
laspse/relapse: A nine-year follow-up of the Chicago CCS/MACS cohort. AIDS and Behavior, 3: 325-334, 1999.
Vanable PA, Ostrow DG, McKirnan DJ, Taywaditep, K, and Hope, B. Impact of combination therapies on HIV risk
perceptions and sexual risk behavior among gay and bisexual men. Health Psychology, 19, 134-145, 2000.
Ostrow DG, Strathdee S, Chmiel J, Fox K, et al. Attitudes towards new HIV treatments predict sexual risk-taking
among HIV- and HIV+ members of the Multicenter AIDS Cohort Study. Abstract selected for oral presentation at 13th International Conference on AIDS, Durban, South Africa, July 9-14th, 2000.
Ostrow DG. The role of drugs in the sexual lives of men who have sex with men: Continuing barriers to researching
this question. AIDS and Behavior, 4:205-219, 2000.
Ostrow DG, Shelby RD. Psychoanalytic and behavioral approaches to drug-related sexual risk taking; a preliminary conceptual and clinical integration. Journal of Gay & Lesbian Psychotherapy, 3:123-139, 2000.
Ostrow DG. HIV incidence trends among gay and bisexual men. FOCUS – A Guide to AIDS Research and Counseling, 16:2, 2001.
Ostrow D, Fox K, Kleeberger C, Jacobson LP, Chmiel JS, Silvestre A, Visscher BR, and Strathdee SA. Psychosocial correlates of incomplete adherence to HIV antiretroviral therapy (HAART): Mental health matters. Abstract selected for poster presentation at the 8th Conference on Retroviruses and Opportunistic Infections, Chicago, February, 2001.
Gilman SE, Cochran SD, Mays VM, Hughes, M, Ostrow, DG, and Kessler, RC. Risk of psychiatric disorders among individuals reporting same-sex partners in the National Comorbidity Survey. American Journal Public Health, June, 2001.
McKirnan DJ, Vanable PA, Ostrow DG, Hope B. Expectancies of sexual "escape" and sexual risk among drug and alcohol-involved gay and bisexual men. J Subst Abuse. 2001;13(1-2):137-54.
Ostrow DE, Fox KJ, Chmiel JS, Silvestre A, Visscher BR, Vanable PA, Jacobson LP, Strathdee SA. Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS. 2002 Mar 29;16(5):775-80.
Vanable PA, Ostrow DG, McKirnan DJ. Viral load and HIV treatment attitudes as correlates of sexual risk behavior among HIV-positive gay men. J Psychosomatic Med, 2003, 54:775-780.
Crawford, I., Hammack, PI., McKirnan, DM., Ostrow, DG., Zamboni, BD., Robinson, B., Hope, B. Sexual sensation seeking, reduced concern about HIV and sexual risk behavior among gay men in primary relationships. AIDS Care, 4:513-524, 2003.
Lui C, Ostrow DG, Detels R, Hu Z, Johnson L, Kingsley L and Jacobson LP. Impacts of HIV Infection and HAART Use on Quality of Life. Accepted for publication, August 2005, Quality of Life.
Silvestre A, Houston C, Johnson L, Hylton J and Ostrow DG. A model for recruiting racial and ethnic minority men who have sex with men into HIV research: A four city campaign. Accepted for publication 12-20-05, AJPH.
Liu C, Johnson L, Ostrow D, Silvestre T, Visscher B and Lisa Jacobson. Predictors of Lower Quality of Life in the HAART Era among HIV-infected Men. Accepted for publication, March 2006, J AIDS.
Ostrow DG, Silverberg M, Cook RC, Chmiel JS, Johnson L, Li X, and Jacobson L. A prospective study of attitudinal and relationship factors as predictors of sexual risk in the MACS. AIDS & Behavior online, April 5, 2007
Plankey MW, Ostrow DG, Cox C, Xihuong L, Stall R, Peck J. Crystal methamphetamine and popper use increase risk of seroconversion in the MACS cohort. JAIDS online, March, 2007
Wilson TE, Vega M, Feldman J, Ghandi M, Cohen M, Richardson J, McKaig R, Ostrow DG, Robison E and Gange S. Acquisition of new sexual partners and condom use among women with HIV-infection: The role of beliefs regarding HIV antiretroviral therapy. AIDS Care online, March, 2007.
Research Support. List selected ongoing or completed (during the last three years) research projects (federal and non-federal support
Current Projects:
Consultant/Chair of the Behavioral Working Group of the MACS, supported by consulting agreements with the four MACS field sites and CAMACS. Involves coordinating and initiating new behavioral research projects within the MACS and across the MACS and WIHS cohort studies. No funding or scientific overlap with the present proposal.
Pending Projects:
NIDA-pending funding decision: Long-term health effects of methamphetamine use in the MACS (Ronald Stall, PI). Would be 3 year look-back/longitudinal study of the effects of methamphetamine (and other stimulants) on physical and mental health outcomes among the men in the MACS. No scientific or budgetary overlap, but there would be considerable synergy if both projects collected new behavioral outcome predictor data at about the same time.
Completed Projects:
Pilot Demonstration Project on HCV Education of Substance Abuse Counselors (2004) This was a SAMSHA-funded 4-year Treatment Optimization Project, within which DGO was PI for the one-year pilot demonstration education project. Included development of needs assessment with Chicago-area SA treatment facilities and staffs; development of survey instrument to gauge levels of knowledge, experience and attitudes towards Hepatitis diagnosis and treatment among SA counselors, and pre-/post-evaluation of changes in these measures due to participation in an intense 1-day educational program.
Copyright Veterans for Medical Marijuana Access